| 1 |
29916838 | Simvastatin reverses multiple myeloma serum-induced prothrombotic phenotype in endothelial cells via ERK 1/2 signalling pathway. | 2018 Sep |
1 |
| 2 |
25861297 | The influence of statin therapy on platelet activity markers in hyperlipidemic patients after ischemic stroke. | 2015 Mar 16 |
1 |
| 3 |
21035882 | Simvastatin administration reduces thromboxane production in subjects taking aspirin: links between aspirin resistance and thrombin generation. | 2012 Jan 12 |
1 |
| 4 |
19631970 | Prior simvastatin treatment is associated with reduced thrombin generation and platelet activation in patients with acute ST-segment elevation myocardial infarction. | 2010 May |
2 |
| 5 |
19014947 | Berberine, a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells. | 2009 Feb |
1 |
| 6 |
19027114 | Tissue factor +5466A>G polymorphism determines thrombin formation following vascular injury and thrombin-lowering effects of simvastatin in patients with ischemic heart disease. | 2009 Jun |
1 |
| 7 |
18658277 | Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibition. | 2008 Oct |
4 |
| 8 |
17477084 | [Estimation of the correlation between hemostatic parameters and serum lipids in patients with hyperlipidemia type II after simvastatin therapy]. | 2007 Jan |
2 |
| 9 |
16775505 | Statins blunt thrombin-induced down-regulation of endothelial nitric oxide synthase expression in human endothelial cells. | 2006 May |
3 |
| 10 |
15853752 | Statins and thrombin. | 2005 Apr |
1 |
| 11 |
15860737 | Rac1 regulation of surface expression of protease-activated receptor-1 and responsiveness to thrombin in vascular smooth muscle cells. | 2005 Jul |
1 |
| 12 |
15980269 | Simvastatin given for 3 days can inhibit thrombin generation and activation of factor V and enhance factor Va inactivation in hypercholesterolemic patients. | 2005 Jul |
1 |
| 13 |
16113803 | Early antithrombotic and anti-inflammatory effects of simvastatin versus fenofibrate in patients with hypercholesterolemia. | 2005 Jul |
2 |
| 14 |
16521918 | [Evaluation of thrombin generation and clot bound thrombin in plasma of hyperlipidemic patients treated with statins]. | 2005 |
2 |
| 15 |
14630613 | Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin. | 2004 May |
2 |
| 16 |
11956113 | Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways. | 2002 Apr 16 |
3 |
| 17 |
12067916 | Rho-GTPase-dependent platelet-neutrophil interaction affected by HMG-CoA reductase inhibition with altered adenosine nucleotide release and function. | 2002 Jun 1 |
1 |
| 18 |
11246536 | Treatment with simvastatin and low-dose aspirin depresses thrombin generation in patients with coronary heart disease and borderline-high cholesterol levels. | 2001 Feb |
4 |
| 19 |
11342472 | Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation. | 2001 May 8 |
2 |
| 20 |
11687759 | Antithrombotic actions of statins. | 2001 Nov-Dec |
1 |
| 21 |
10704621 | Inhibition of tissue-factor-mediated thrombin generation by simvastatin. | 2000 Mar |
2 |
| 22 |
10830219 | Simvastatin attenuates vascular hypercoagulability in cardiac transplant recipients. | 2000 May 15 |
2 |
| 23 |
11104736 | Simvastatin improves disturbed endothelial barrier function. | 2000 Dec 5 |
2 |
| 24 |
10193729 | Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia. | 1999 Apr |
3 |